Started “Gungbon Pharmacy”

Closed due to Japan’s corporate restructuring law

Started “Chong Kun Dang Pharmacy”

Founded “Taekwang Chemical Laboratory”

Chungjeongro Pharmaceutical Factory after returning to the capital

Incorporated Chong Kun Dang Pharmaceutical Co., Ltd.

The first technical cooperation(with Leo Pharma, Denmark)

Constructed Chungjeong-ro Office

Constructed a synthesis plant. The first success of synthesizing Chloramphenicol in Korea

US FDA approval for Chloramphenicol

Changed name to Chong Kun Dang Pharmaceutical Corp. Exported Chloramphenicol to Japan

Established Central Research Laboratories

Constructed an antibiotic fermentation plant

Pinned Rifamycin, the anti-tuberculosis drug successful at fermentation for the 4th time in the world Completed Chong Kun Dang Building

The second success of synthesizing Bacampicillin HCI in the world

US FDA approval for Rifampicin

Launched OMP a peptic ulcer remedy

Central Research Laboratories expanded and reorganized into CKD Research Institute(technology labs and new drug discovery labs) Launched DILATREND an antihypertensive agent Launched CIPOL·N an immunosuppressive agent

Cheonan GMP Plant completed Launched LOVALORD an antihyperlipidaemic agent

Launched CAMTOBELL a new anticancer drug Launched ANYDIPINE an antihypertensive agent

Launched TACROBELL an immunosuppressive agent

Launched PREGREL an antiplatelet agent Launched LIPILOU an antihyperlipidaemic agent

Moved CKD Research Institute to Yongin in 2011 and changed name to CKD Hyojong Research Institute